CORC

在结果中检索

CORC

浏览/检索结果: 共37条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文
CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1
作者:  Wu, Chunyan;  Shao, Zhimin;  Xu, Binghe;  Zhang, Qingyuan;  Xu, Ruihua
收藏  |  浏览/下载：123/0  |  提交时间：2019/12/05
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer 期刊论文
2019
作者:  Ma Fei;  Guan Yanfang;  Yi Zongbi;  Chang Lianpeng;  Li Qiao
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China 期刊论文
2019, 卷号: 125, 期号: 5, 页码: 742-749
作者:  Huang, Jing;  Mo, Hongnan;  Zhang, Weilong;  Chen, Xuelian;  Qu, Dong
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody 期刊论文
2019, 卷号: 10, 期号: 6, 页码: 1395-1401
作者:  Wang, Xi;  Zhang, Bo;  Chen, Xuelian;  Mo, Hongnan;  Wu, Dawei
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 1
作者:  Guan, Xiuwen;  Ma, Fei;  Li, Chunxiao;  Wu, Shiyang;  Hu, Shangying
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes 期刊论文
2019, 卷号: 8, 期号: 5, 页码: 2074-2084
作者:  Wang, Jiayu;  Li, Weiwei;  Shi, Yujian;  Huang, Yan;  Sun, Tao
收藏  |  浏览/下载：28/0  |  提交时间：2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210 期刊论文
2019, 卷号: 16, 期号: 1, 页码: 173-+
作者:  Chen, Xuelian;  Ma, Lanying;  Wang, Xi;  Mo, Hongnan;  Wu, Dawei
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文
2019, 卷号: 16, 期号: 1, 页码: 189-204
作者:  Zhang Xuchao;  Liang Zhiyong;  Wang Shengyue;  Lu Shun;  Song Yong
收藏  |  浏览/下载：25/0  |  提交时间：2020/01/03
Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as AminopeptidaseN (APN) Inhibitors 期刊论文
CHEMMEDCHEM, 2018, 卷号: 13, 期号: 5, 页码: 431-436
作者:  Cao, Jiangying;  Zang, Jie;  Ma, Chunhua;  Li, Xiaoguang;  Hou, Jinning
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace